|Bid||61.19 x 800|
|Ask||62.00 x 3200|
|Day's Range||60.10 - 62.10|
|52 Week Range||53.91 - 71.65|
|Beta (3Y Monthly)||0.84|
|PE Ratio (TTM)||17.62|
|Earnings Date||May 6, 2019 - May 10, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||63.46|
A few years ago I was sitting in the dentist chair for my six-month examination and teeth cleaning. As I stared at the ceiling, I couldn't help notice the name Belmont on the arm of the bright light burning a hole in my retina. I couldn't help myself, asking the dentist if she'd ever invested in a dental-related company? She said she hadn't. "Not even Henry Schein (NASDAQ:HSIC)?", I asked. Nope. That was the end of the investment discussion. Recently, I saw an article that said dental startups such as Candid and Smile Direct Club, which provides systems for mild-to-moderate teeth straightening -- saving you a bundle in the process -- have investors lining up to invest in the private companies. InvestorPlace - Stock Market News, Stock Advice & Trading TipsOf course, that brought me back to that day in the dentist's chair, when I wondered about stocks to buy that will make you smile. * 10 Stocks That Are Screaming Buys Right Now Here are seven names I've identified that will put money in your pockets. Henry Schein (HSIC)Source: Shutterstock If you're a dentist, you've likely got Henry Schein on speed dial. It distributes more than 120,000 branded products and another 180,000 private label products to dentists and medical practitioners. It is the No. 1 global dental distributor and the No. 2 physician and alternate care distributor in the U.S. In fact, 90% of U.S. dental practices are active Schein customers. So, the next time you go to the dentist, be sure to ask how much stuff they buy from the company. It's probably a lot. Things seem to be going smoothly for the Melville, New York, company, yet HSIC is currently trading within 13% of its 52-week low and up less than 5% year-to-date through April 10, one-third the performance of the S&P 500.On three occasions over the past five years, it traded below $55. Within five dollars of doing so a fourth time, HSIC is entering value territory. Fear not. In 2018, Henry Schein's revenues grew by 5.9% year-over-year to $13.2 billion, while its non-GAAP earnings rose 11.4% to $635.3 million, its highest level of sales and profits in its history. Now, exclusively a company dealing with humans after spinning off its animal health business, Henry Schein is ready to take dental to the next level. 3D Systems (DDD)Source: Image via 3D Systems3D Systems (NYSE:DDD) is a 3D printer. Over the past five years as the demand for 3D printing has slowed, so too has the company's revenue and earnings growth. As a result, DDD shares have lost 80% of their value. In 2019, DDD is up more than 7% year-to-date through April 10. However, it lost a great deal of its momentum in March, giving back 23% of its gains on the year. The company's dental segment continues to take a bite out of the competition. It produces dentures, crowns and surgical guides. "There are billions of opportunities here, since virtually anybody could benefit from 3-D printed dental solutions," said CEO Vyomesh Joshi recently. On a non-GAAP basis, 3D Systems went from a $1.7 million loss in 2017 to a $16.5 million gain in 2018 on the strength of a 6% increase in revenue to $688 million. * 10 Dow Jones Stocks Holding the Blue Chip Index Back Trading at 1.8 times revenue, less than half its five-year average price-to-sales ratio, DDD provides investors with an excellent value proposition. Align Technology (ALGN)Source: Shutterstock As dentists go, mine wasn't too pushy about trying the latest and greatest dental product or service, but she sure liked to talk up Invisalign, the $8,000 clear aligner that straightens your teeth. Made by Align Technology (NASDAQ:ALGN), I never took the bait. Now, having moved from Toronto to Halifax over a year ago, and still without a new dentist, I suspect I'll soon be getting the Invisalign sales pitch a second time. Perhaps, startups like Candid are taking a bite out of Align's market share. Given the $4,000 price over 24 months for its teeth alignment product, a good $3,000-$4,000 cheaper than the competition, it's easy to see why. However, I don't think investors should give up on ALGN just yet. As I look at the company's results for 2018, I see a lot of positives.On the top line, revenues grew 34% to $2 billion, a company record, on a 32% increase in Invisalign volume. On the bottom line, net profits were $400.2 million in 2018, 73% higher than a year ago. Forget for a moment that Invisalign didn't exist. Its iTero scanners experienced 68% growth in 2018; iTero's revenues now account for 14% of Align's overall revenue, up 290 basis points from 2017. Trading well off its all-time high of $398.88, investors buying in today, should have significant upside in the months ahead. Dentsply Sirona (XRAY)Source: Shutterstock I first became familiar with Dentsply Sirona (NASDAQ:XRAY) way back in March 2013, more than two years before Dentsply would pay $5.5 billion for Sirona Dental Systems, a company I liked because of its diversified revenue streams. "Sirona's revenue diversification is what makes it such a good company. It generates business from four operating segments: Dental CAD/CAM Systems, Imaging Systems, Treatment Centers, and Instruments," I wrote March 20, 2013. "Its CAD/CAM and Imaging Systems accounted for 70% of its overall revenue in the first quarter ended December 2012."If you took my advice and bought 100 shares of Sirona at the Q2 2013 high of $73.98, today you'd have $9,158, a 24% return. But over three years, it's seen a mediocre 5% return. So, do I still think XRAY is worth holding for the long haul?I do. Here's why.Like most acquisitions, the tie-up didn't go nearly as smoothly as hoped. As a result, the company was forced to implement a turnaround plan that will simplify its business. Where have I heard that before?Anyway, when you bring together two reasonably large businesses, you often lose focus on parts of it and those units suffer. So, it's exiting these businesses and cutting staffing by as much as 8%. By fiscal 2020, analysts expect it to earn $2.64 a share, its best earnings performance since 2016. * The 7 Best Long-Term Stocks for 2019 And Beyond It has had a good run in 2019, up 36% year-to-date. I'd be patient and try to buy on weakness in the mid-$40s. Patterson Companies (PDCO)Source: Shutterstock A little over two years ago, Globe and Mail business reporter Scott Barlow highlighted 12 healthcare stocks that had stable cash flow. He argued that businesses such as Patterson Companies (NASDAQ:PDCO), a distributor of dental and animal health products, would make you rich over the long haul because of this critical attribute. Since the article, PDCO stock has lost approximately half its value. Ouch.However, in the nine months ended Jan. 27, 2019, Patterson's operating cash flow increased 91% to $76.3 million. After subtracting $33.9 million in capital expenditures, it generated free cash flow of $42.4 million or 77% of its net income. On the top line, revenues in the first three quarters of fiscal 2019 barely budged, up 1.8% to $4.14 billion. On the bottom line GAAP basis, its net income fell 69% to $55.2 million. On an adjusted basis, earnings fell 25% to $95.9 million. While this article is about dental businesses, Patterson's animal health business (58% of revenue) continues to provide PDCO with diversified revenue streams that will protect it when the economy turns south because a lot of pet owners won't scrimp on their companion animal's wellbeing. Yielding 4.8% at the moment, it has plenty of free cash flow to keep paying its juicy dividend. If you're an income investor, PDCO is an excellent stock to own before the company's restructuring takes hold. Get paid to wait. Procter & Gamble (PG)Source: Mike Mozart via Flickr (Modified)My old dentist's dental technician recommended that I buy an Oral-B electric toothbrush because it does a better job of brushing your teeth without overdoing it, thus hurting your gums. She was right. Originally invented in 1950 by California periodontist Dr. Robert Hutson, he sold the company to Cooper Laboratories, who in turn sold it to Gillette in 1984 for $188.5 million. The rest, as they say, is history. On April 9, Oral-B's owner, Procter & Gamble (NYSE:PG), raised its quarterly dividend by 4% to 74.59 cents a share, an annualized rate of $2.98, yielding 2.8% despite a 37% gain over the past 52 weeks. This is P&G's 63rd consecutive year increasing its dividend. Oral-B and the rest of its oral care brands generated 9% of P&Gs revenue in the second quarter. Part of the healthcare segment, sales and earnings were both up slightly in the first quarter, delivering solid if not spectacular results. * The 10 Fastest-Growing Stocks to Invest In Right Now Consider Oral-B the company's slow-growth business. Overall, however, Procter & Gamble is doing just fine. Church & Dwight (CHD) Source: slgckgc via Flickr (Modified)Church & Dwight (NYSE:CHD) is a smaller version of P&G. But make no mistake, it competes with the best of them. As far as dental care goes, it has Arm & Hammer, AIM, Close-Up and Pepsodent toothpaste. Other brands include Orajel and Waterpik. The company has become adept at making smaller acquisitions and then growing those businesses over time. Most recently, it announced it had acquired two hair removal brands, Flawless and Finishing Touch, for $475 million and a further $425 million in potential earnouts. The two brands add $180 million in annual revenue and $55 million in EBITDA.The owners of Flawless would have been wise to ask for stock instead of cash because over the past decade, CHD stock has delivered an annualized total return of 19.4%, almost double P&G.As stocks go, CHD is a perfect 10. I urge you to check it out. At the time of this writing, Will Ashworth did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Internet Stocks to Watch * 7 AI Stocks to Watch with Strong Long-Term Narratives * 10 Dow Jones Stocks Holding the Blue Chip Index Back Compare Brokers The post 7 Dental Stocks to Buy That Will Make You Smile appeared first on InvestorPlace.
Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! Analyzing Henry Schein, Inc.'s (NASDAQ:HSIC) track record of past performance is a valuable exercise for investors. It enable...
Henry Schein Inc NASDAQ/NGS:HSICView full report here! Summary * ETFs holding this stock are seeing positive inflows * Bearish sentiment is moderate * Economic output in this company's sector is expanding Bearish sentimentShort interest | NegativeShort interest is moderately high for HSIC with between 10 and 15% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | PositiveETF activity is positive. Over the last month, growth of ETFs holding HSIC is favorable, with net inflows of $29.53 billion. This is among the highest net inflows seen over the last one-year and the rate of additional inflows appears to be increasing. Economic sentimentPMI by IHS Markit | PositiveAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year, and is accelerating. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to email@example.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Nearly $525,000 in Funds and Health Care Products Donated to Support 12 Pediatric Health Programs MELVILLE, N.Y. , April 9, 2019 /PRNewswire/ -- Henry Schein Medical, the U.S. medical business of Henry ...
MELVILLE, N.Y., April 8, 2019 /PRNewswire/ -- Henry Schein, Inc. (HSIC) demonstrated its commitment to expanding access to health care and developing high-level capabilities in oral health leaders from around the world by sponsoring the Senior Dental Leaders Programme for a 13th year. First conceived in 2007 at King's College London by Professor Raman Bedi, DDS, the programme is attended by a diverse cohort from within the international dental community working collaboratively toward a cavity-free world for children, including dental policymakers, national Chief Dental Officers, representatives from non-governmental organizations, members of the clinical and academic communities, and other stakeholders.
We can judge whether Henry Schein, Inc. (NASDAQ:HSIC) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their ideas. There's no better way to get these firms' immense resources and analytical capabilities working for us than to follow their lead into their best […]
MELVILLE, N.Y., March 28, 2019 /PRNewswire/ -- Henry Schein, Inc. (HSIC) today announced that it received a perfect score of 100 on the 2019 Corporate Equality Index (CEI), the nation's premier benchmarking survey and report on corporate policies and practices related to LGBTQ workplace equality, administered by the Human Rights Campaign (HRC) Foundation. Henry Schein joins the ranks of more than 560 major U.S. businesses that also earned top marks this year. "Henry Schein has long embraced diversity and inclusion as core values, so it is a tremendous honor to be recognized for our commitment to LGBTQ workplace equality by the Human Rights Campaign Foundation," said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein.
Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! Many investors define successful investing as beating the market averageRead More...
Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
MELVILLE, N.Y., March 20, 2019 /PRNewswire/ -- Henry Schein, Inc. (HSIC) reminds its customers in the Midwest that the Henry Schein Disaster Relief Hotline is open for dentists and physicians who may experience operational, logistical, or financial issues as a result of damage caused by the recent flooding. The toll-free number for all Henry Schein customers is 800-999-9729. The hotline is open 24/7, with real-time assistance available from Team Schein Members from 8 a.m. to 7 p.m. ET.
CEO Stanley Bergman to Open the Nasdaq Stock Market in Recognition of 20th Anniversary MELVILLE, N.Y. , March 19, 2019 /PRNewswire/ -- Henry Schein Financial Services (HSFS), a subsidiary of Henry Schein ...
AMERICAN FORK, Utah, March 18, 2019 /PRNewswire/ -- Henry Schein, Inc. (HSIC), through its Henry Schein One joint venture, today announced that it has acquired Lighthouse 360, a provider of easy-to-use dental practice management and patient communication software that complements Henry Schein One's strategy to deliver integrated technology platforms that help dental teams become more productive and improve each stage of the patient experience. Founded in 2006, Lighthouse 360 was previously a part of Web.com and had 2018 sales of approximately $50 million. Henry Schein, Inc. expects that Lighthouse 360 will be neutral to the Company's 2019 earnings per diluted share and accretive thereafter.
NEW YORK, March 06, 2019 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
Yesterday was yet another indecisive day that essentially ended where it started. The S&P 500 slipped 0.11% on Tuesday, content to linger where it's been for the past week and a half.General Electric (NYSE:GE) proved to be the biggest drag. Shares of the beleaguered industrial giant fell 4.7% after the company cautioned its industrial free cash flow this year wouldn't be as strong as investors were expecting. Free cash flow may be the one thing investors need to see improve more than any other.Aurora Cannabis (NYSE:ACB) jumped 12.2% after Cowen Equity Research's enthusiastic coverage was unveiled, while China's electric vehicle maker Nio (NYSE:NIO) saw its stock gain 3.9% in front of its post-close earnings report. But, neither are key index components. In fact, Nio shares fell more than 14% in Tuesday's after-hours action.InvestorPlace - Stock Market News, Stock Advice & Trading TipsAs Wednesday's trading gets going, the stocks charts of Alaska Air Group (NYSE:ALK), Henry Schein (NASDAQ:HSIC) and PulteGroup (NYSE:PHM) are of the most interest. It looks as if they're not being bogged down by the broad market's overall lethargy, being allowed to set up some explosive movement. PulteGroup (PHM)PulteGroup was down more than a little bit yesterday, but one has to take a step back to put it on context. Tuesday's weakness was more of the same traversing of an ever-narrowing trading range that's quickly pushing PHM to an inflection point. * 7 Chinese Stocks to Buy for the 2019 Rebound In fact, either the bulls or the bears are going to have to make a decision within the next few days. It could still go either way, but whatever's in store should be a big move. Click to Enlarge • The converging wedge pattern is plotted with yellow dashed lines on both stock charts. There's very little room left between these support and resistance levels.• Also in play is the convergence of the purple 50-day moving average line and the white 200-day line. If the former moves above the latter, that's a buy signal in and of itself.• Though the momentum is technically bullish, there's a distinct lack of volume behind the gains thus far. The rally needs more participation if it's going to last. Henry Schein (HSIC)Were it not already in more than a little technical trouble, the daily and weekly stocks charts of medical supply company Henry Schein wouldn't be of particular interest. But, with a headwind in place and a major support level in sight, it's worth a closer look. One or two more bad days could put some more serious selling into motion. Click to Enlarge • The big floor in question is the horizontal resistance around $57.64, plotted with a white dashed line on both stock charts. That support has kept shares propped up with each key low since late December.• But, HSIC shares continue to test that level as support in the shadow of the purple 50-day moving average line's cross below the white 200-day moving average line. This so-called "death cross" often precedes a sizeable pullback.• Zooming out to the weekly chart of Henry Schein, was can see that the $57.64 area has not only been a floor before, we can see an up-and-down pattern that may not have fully played out yet. The RSI line needs to be much closer to 30 before the selling has fully exhausted. Alaska Air Group (ALK)Finally, with nothing more than a quick glance it looks like Alaska Air Group shares are in trouble. And, maybe they are.But, this is a scare we've seen many, many times from ALK before, just within the past few weeks. All of them abruptly ended with a sharp bounceback, and the early indications are that this one will end with the same result. Click to Enlarge • While sharply lower on Tuesday to top off a week-long rout, yesterday's low and close also more or less lines up with the big lows hit five different times now since April of last year.• Although repeated tests of a technical floor will eventually break it, Tuesday's volume surge actually flags something of a mini-capitulation.• On the other hand, a string of failed breakout attempts can discourage future attempts. Note that all the key moving average lines are now sloped downward, saying the undertow is leaning in a bearish direction.As of this writing, James Brumley did not hold a position in any of the aforementioned securities. You can learn more about James at his site, jamesbrumley.com, or follow him on Twitter, at @jbrumley. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Big Data Stocks That Deserve a Closer Look * 7 Best Energy Funds to Outperform the Market * 5 Blue-Chip Stocks Ready to Rise Compare Brokers The post 3 Big Stock Charts for Wednesday: Henry Schein, Alaska Air Group and PulteGroup appeared first on InvestorPlace.
Henry Schien (HSIC) believes that acquisition of NAR's business will offer multiple growth opportunities and promising business synergies.
Henry Schein, Inc. (HSIC) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.
MELVILLE, N.Y., March 4, 2019 /PRNewswire/ -- Henry Schein, Inc. (HSIC), the world's largest provider of health care products and services to office-based dental and medical practitioners, today announced it has completed the acquisition of North American Rescue (NAR), the leading provider of survivability and casualty-care medical products to the defense and public-safety markets. As previously reported, NAR generated record sales for the 12 months ended October 31, 2018, of approximately $184 million. As stated when Henry Schein announced its agreement with NAR, Henry Schein expects NAR to be neutral to the Company's 2019 earnings per share and accretive thereafter.
MELVILLE, N.Y., Feb. 27, 2019 /PRNewswire/ -- Henry Schein, Inc. (HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the 2019 Barclays Global Healthcare Conference in Miami on Wednesday, March 13, 2019, at 10:45 a.m. Eastern time. Henry Schein's presentation can be heard via live webcast by visiting www.henryschein.com, clicking on "Investor Relations," and following the link for "Webcasts." A replay will be available on the Henry Schein website following the presentation. Henry Schein, Inc. (HSIC) is a solutions company for health care professionals powered by a network of people and technology.
MELVILLE, N.Y., Feb. 26, 2019 /PRNewswire/ -- Henry Schein, Inc. (HSIC), the world's largest provider of health care products and services to office-based dental and medical practitioners, has been recognized by the Ethisphere Institute, a global leader in defining and advancing the standards of ethical business practices, as one of the 2019 World's Most Ethical Companies. This is the eighth consecutive year that Henry Schein has been recognized, and it is the only honoree in the Healthcare Products industry, underscoring the company's commitment to delivering the solutions health care professionals rely on to improve the performance of their practice so they can improve the lives of patients.
Ringing today's opening bells are the U.S. Department of Agriculture with Agriculture Secretary Sonny Perdue at the NYSE and Henry Schein Financial Services with Chairman and CEO Stanley Bergman, EVP and CFO Steven Paladino, and Henry Schein Financial Services Vice President and General Manager Keith Drayer at the Nasdaq.